British Journal of Ophthalmology · 2015 · 10 citations · 19 references
MedicineSurgeryOrofacial PainPain ManagementPain MedicineInflammatory LesionsOrbital DiseaseOrbital ImagingOrbital InflammationOrbital PathologyOrbital SurgeryDisease Incidence RateIncidence RateInflammatory Orbital Disease ImagingOrbital Inflammatory SyndromeOrbital NervesOutcome MeasuresRecurrence Rate AnalysisTreatment Outcome Analysis
PURPOSE: To investigate the clinical characteristics of idiopathic orbital inflammatory (IOI) disease with infraorbital nerve (ION) enlargement. DESIGN: Retrospective, comparative case series. PARTICIPANTS: Consecutive patients who were diagnosed with IOI between January 2009 and December 2013 were identified. The study included patients whose medical and radiological data at diagnosis were available and whose follow-up period was more than 12 months after treatment. The patients were divided into two groups according to accompaniment of ION enlargement and were compared. MAIN OUTCOME MEASURES: clinical manifestation, radiology and treatment outcome. RESULTS: Among 89 patients with IOI, 12 (13.5%) were identified to have ION enlargement. The ION-enlarged group showed a higher percentage of the patients with diffuse inflammation (66.7%, p<0.001). 91.7% of the ION-enlarged group showed inferiorly located inflammation. Patients with ION enlargement showed a significantly higher incidence rate of proptosis (p=0.013), pain (p=0.004) and altered sensation (p<0.001). The recurrence rate was significantly higher in the ION-enlarged group (83.3%) than in the other group (33.8%) (p=0.001). Repetitive inflammation (recurrence ≥3) with steroid dependency was found only in 19.5% patients without ION enlargement but in 66.7% patients with ION enlargement. CONCLUSIONS: Patients with ION-enlarged IOI showed distinct clinical and radiological characteristics. As IOI accompanied by ION enlargement showed significantly higher steroid dependency and recurrence rate, a more careful follow-up of patients during steroid tapering might be helpful to prevent recurrence of IOI.
19
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details
Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki et al. · Modern Rheumatology · 2012 · 691 citations · Full text
Life Sciences, Nephrology, Pathology +13
Idiopathic Orbital Inflammation
Sonia J. Ahn · Archives of Ophthalmology · 2003 · 423 citations
Medicine, Ophthalmology, Surgery +17
Idiopathic orbital inflammatory syndrome: Clinical features and treatment outcomes
Brighu Swamy, Peter McCluskey, Achia Nemet et al. · British Journal of Ophthalmology · 2007 · 208 citations · Full text
Medicine, Ophthalmology, Pathology +17
Orbital Inflammation With IgG4-Positive Plasma Cells
Jose A. Plaza · Archives of Ophthalmology · 2011 · 173 citations
Medicine, Ophthalmology, Pathology +17
Are Systemic Corticosteroids Useful in the Management of Orbital Pseudotumors?
Ilse Mombaerts, Reinier O. Schlingemann, Roel Goldschmeding et al. · Ophthalmology · 1996 · 172 citations
Medicine, Pharmacotherapy, Surgery +12